| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | BHLHE41 ZNF384 ZNF492 ZNF845 ZNF573 ZNF211 ZNF266 ZNF658 ZNF180 ZNF780B ZNF184 ZNF267 ZNF208 ZNF225 ZNF226 ZNF227 ZNF519 ZNF442 ZBTB42 ZNF354C CASZ1 ZNF71 ZNF331 ZNF250 ZNF668 ZNF836 ZNF676 CPHXL ZFHX4 ZNF544 NFATC3 ZNF43 ZNF540 ZNF197 ZNF724 ZNF727 ZNF480 ZNF525 ZNF770 ZNF766 ZNF528 ZNF107 ZBTB18 ZNF726 ZNF730 ZNF426 ZNF287 ZNF345 | 3.32e-16 | 1412 | 179 | 48 | GO:0000981 |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | BHLHE41 ZNF384 ZNF492 ZNF845 ZNF573 ZNF211 ZNF266 ZNF658 RBL1 ZNF180 ZNF780B ZNF184 ZNF267 ZNF208 ZNF225 ZNF226 ZNF227 ZNF519 ZNF442 ZNF354C CASZ1 ZNF71 ZNF331 ZNF250 ZNF668 ZNF836 ZNF676 CPHXL ZFHX4 ZNF544 NFATC3 ZNF43 ZNF540 ZNF197 ZNF724 ZNF727 ZNF480 ZNF525 ZNF770 ZNF766 ZNF528 ZNF107 ZNF726 ZNF730 ZNF426 ZNF287 ZNF345 | 5.66e-15 | 1459 | 179 | 47 | GO:0000977 |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | BHLHE41 ZNF384 ZNF492 ZNF845 ZNF573 ZNF211 ZNF658 ZNF780B ZNF184 ZNF267 ZNF208 ZNF225 ZNF226 ZNF227 ZNF519 ZNF354C ZNF71 ZNF331 ZNF250 ZNF668 ZNF836 ZNF676 CPHXL ZFHX4 ZNF544 NFATC3 ZNF43 ZNF540 ZNF197 ZNF724 ZNF727 ZNF480 ZNF525 ZNF770 ZNF766 ZNF528 ZNF107 ZNF726 ZNF730 ZNF426 ZNF287 ZNF345 | 4.65e-14 | 1244 | 179 | 42 | GO:0000978 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | BHLHE41 ZNF384 ZNF492 ZNF845 ZNF573 ZNF211 ZNF658 ZNF780B ZNF184 ZNF267 ZNF208 ZNF225 ZNF226 ZNF227 ZNF519 ZNF354C ZNF71 ZNF331 ZNF250 ZNF668 ZNF836 ZNF676 CPHXL ZFHX4 ZNF544 NFATC3 ZNF43 ZNF540 ZNF197 ZNF724 ZNF727 ZNF480 ZNF525 ZNF770 ZNF766 ZNF528 ZNF107 ZNF726 ZNF730 ZNF426 ZNF287 ZNF345 | 9.59e-14 | 1271 | 179 | 42 | GO:0000987 |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | ZNF384 ZNF845 ZNF658 ZNF780B ZNF267 ZNF208 ZNF225 ZNF226 ZNF227 ZNF519 CASZ1 ZNF71 ZNF668 ZNF836 ZNF544 NFATC3 ZNF43 ZNF197 ZNF727 ZNF770 ZNF107 ZNF726 ZNF345 | 1.25e-09 | 560 | 179 | 23 | GO:0001228 |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | ZNF384 ZNF845 ZNF658 ZNF780B ZNF267 ZNF208 ZNF225 ZNF226 ZNF227 ZNF519 CASZ1 ZNF71 ZNF668 ZNF836 ZNF544 NFATC3 ZNF43 ZNF197 ZNF727 ZNF770 ZNF107 ZNF726 ZNF345 | 1.54e-09 | 566 | 179 | 23 | GO:0001216 |
| GeneOntologyMolecularFunction | interleukin-1 receptor activity | 3.84e-05 | 8 | 179 | 3 | GO:0004908 | |
| GeneOntologyMolecularFunction | NAD+ nucleosidase activity | 1.47e-04 | 12 | 179 | 3 | GO:0003953 | |
| GeneOntologyMolecularFunction | NAD+ nucleotidase, cyclic ADP-ribose generating | 3.64e-04 | 16 | 179 | 3 | GO:0061809 | |
| GeneOntologyMolecularFunction | growth factor binding | 5.25e-04 | 156 | 179 | 7 | GO:0019838 | |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity, RNA polymerase II-specific | BHLHE41 ZNF208 ZNF354C ZNF668 NFATC3 ZNF43 ZNF727 ZNF107 ZBTB18 ZNF726 | 6.44e-04 | 320 | 179 | 10 | GO:0001227 |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity | BHLHE41 ZNF208 ZNF354C ZNF668 NFATC3 ZNF43 ZNF727 ZNF107 ZBTB18 ZNF726 | 7.43e-04 | 326 | 179 | 10 | GO:0001217 |
| GeneOntologyMolecularFunction | transmembrane receptor protein kinase activity | 1.01e-03 | 85 | 179 | 5 | GO:0019199 | |
| GeneOntologyCellularComponent | collagen type I trimer | 7.37e-05 | 2 | 180 | 2 | GO:0005584 | |
| Domain | zf-C2H2_6 | ZNF384 ZNF492 ZNF845 ZNF573 ZNF211 ZNF266 ZNF658 ZNF780B ZNF184 ZNF267 ZNF208 ZNF225 ZNF227 ZNF442 ZNF354C ZNF71 ZNF331 ZNF250 ZNF668 ZNF836 ZNF676 ZNF43 ZNF540 ZNF197 ZNF727 ZNF480 ZNF770 ZNF766 ZNF107 ZNF726 ZNF730 ZNF426 ZNF345 | 3.59e-25 | 314 | 176 | 33 | PF13912 |
| Domain | KRAB | ZNF492 ZNF845 ZNF573 ZNF211 ZNF266 ZNF658 ZNF180 ZNF780B ZNF184 ZNF267 ZNF208 ZNF225 ZNF226 ZNF227 ZNF519 ZNF235 ZNF442 ZNF354C ZNF331 ZNF250 ZNF836 ZNF676 ZNF544 ZNF43 ZNF540 ZNF197 ZNF727 ZNF480 ZNF766 ZNF528 ZNF726 ZNF730 ZNF426 ZNF287 | 1.82e-24 | 358 | 176 | 34 | PS50805 |
| Domain | zf-C2H2 | ZNF384 ZNF492 ZNF845 ZNF573 ZNF211 ZNF266 ZNF658 ZNF180 ZNF780B ZNF184 ZNF267 ZNF208 ZNF225 ZNF226 ZNF227 ZNF519 ZNF235 ZNF442 ZNF354C CASZ1 ZNF71 ZNF331 ZNF250 ZNF668 ZNF836 ZNF676 ZFHX4 ZNF544 ZNF43 ZNF540 ZNF197 ZNF727 ZNF480 ZNF525 ZNF770 ZNF766 ZNF528 ZNF107 ZBTB18 ZNF726 ZNF730 ZNF426 ZNF287 ZNF345 | 2.01e-24 | 693 | 176 | 44 | PF00096 |
| Domain | ZINC_FINGER_C2H2_1 | ZNF384 ZNF492 ZNF845 ZNF573 ZNF211 ZNF266 ZNF658 ZNF180 ZNF780B ZNF184 ZNF267 ZNF208 ZNF225 ZNF226 ZNF227 ZNF519 ZNF235 ZNF442 ZBTB42 ZNF354C CASZ1 ZNF71 ZNF331 ZNF250 ZNF668 ZNF836 ZNF676 ZFHX4 ZNF544 ZNF43 ZNF540 ZNF197 CIZ1 ZNF727 ZNF480 ZNF525 ZNF770 ZNF766 ZNF528 ZNF107 ZBTB18 ZNF726 ZNF730 ZNF426 ZNF287 ZNF345 | 2.77e-24 | 777 | 176 | 46 | PS00028 |
| Domain | KRAB | ZNF492 ZNF845 ZNF573 ZNF211 ZNF266 ZNF658 ZNF180 ZNF780B ZNF184 ZNF267 ZNF208 ZNF225 ZNF226 ZNF227 ZNF519 ZNF235 ZNF442 ZNF354C ZNF331 ZNF250 ZNF836 ZNF676 ZNF544 ZNF43 ZNF540 ZNF197 ZNF727 ZNF480 ZNF766 ZNF528 ZNF726 ZNF730 ZNF426 ZNF287 | 4.93e-24 | 369 | 176 | 34 | SM00349 |
| Domain | KRAB | ZNF492 ZNF845 ZNF573 ZNF211 ZNF266 ZNF658 ZNF180 ZNF780B ZNF184 ZNF267 ZNF208 ZNF225 ZNF226 ZNF227 ZNF519 ZNF235 ZNF442 ZNF354C ZNF331 ZNF250 ZNF836 ZNF676 ZNF544 ZNF43 ZNF540 ZNF197 ZNF727 ZNF480 ZNF766 ZNF528 ZNF726 ZNF730 ZNF426 ZNF287 | 5.39e-24 | 370 | 176 | 34 | IPR001909 |
| Domain | Znf_C2H2 | ZNF384 ZNF492 ZNF845 ZNF573 ZNF211 ZNF266 ZNF658 ZNF180 ZNF780B ZNF184 ZNF267 ZNF208 ZNF225 ZNF226 ZNF227 ZNF519 ZNF235 ZNF442 ZBTB42 ZNF354C CASZ1 ZNF71 ZNF331 ZNF250 ZNF668 ZNF836 ZNF676 ZFHX4 ZNF544 ZNF43 ZNF540 ZNF197 CIZ1 ZNF727 ZNF480 ZNF525 ZNF770 ZNF766 ZNF528 ZNF107 ZBTB18 ZNF726 ZNF730 ZNF426 ZNF287 ZNF345 | 1.21e-23 | 805 | 176 | 46 | IPR007087 |
| Domain | ZnF_C2H2 | ZNF384 ZNF492 ZNF845 ZNF573 ZNF211 ZNF266 ZNF658 ZNF180 ZNF780B ZNF184 ZNF267 ZNF208 ZNF225 ZNF226 ZNF227 ZNF519 ZNF235 ZNF442 ZBTB42 ZNF354C CASZ1 ZNF71 ZNF331 ZNF250 ZNF668 ZNF836 ZNF676 ZFHX4 ZNF544 ZNF43 ZNF540 ZNF197 CIZ1 ZNF727 ZNF480 ZNF525 ZNF770 ZNF766 ZNF528 ZNF107 ZBTB18 ZNF726 ZNF730 ZNF426 ZNF287 ZNF345 | 1.42e-23 | 808 | 176 | 46 | SM00355 |
| Domain | Znf_C2H2/integrase_DNA-bd | ZNF384 ZNF492 ZNF845 ZNF573 ZNF211 ZNF266 ZNF658 ZNF180 ZNF780B ZNF184 ZNF267 ZNF208 ZNF225 ZNF226 ZNF227 ZNF519 ZNF235 ZNF442 ZBTB42 ZNF354C ZNF71 ZNF331 ZNF250 ZNF668 ZNF836 ZNF676 ZFHX4 ZNF544 ZNF43 ZNF540 ZNF197 ZNF727 ZNF480 ZNF770 ZNF766 ZNF528 ZNF107 ZBTB18 ZNF726 ZNF730 ZNF426 ZNF287 ZNF345 | 1.94e-23 | 694 | 176 | 43 | IPR013087 |
| Domain | ZINC_FINGER_C2H2_2 | ZNF384 ZNF492 ZNF845 ZNF573 ZNF211 ZNF266 ZNF658 ZNF180 ZNF780B ZNF184 ZNF267 ZNF208 ZNF225 ZNF226 ZNF227 ZNF519 ZNF235 ZNF442 ZBTB42 ZNF354C CASZ1 ZNF71 ZNF331 ZNF250 ZNF668 ZNF836 ZNF676 ZFHX4 ZNF544 ZNF43 ZNF540 ZNF197 ZNF727 ZNF480 ZNF525 ZNF770 ZNF766 ZNF528 ZNF107 ZBTB18 ZNF726 ZNF730 ZNF426 ZNF287 ZNF345 | 2.14e-23 | 775 | 176 | 45 | PS50157 |
| Domain | Znf_C2H2-like | ZNF384 ZNF492 ZNF845 ZNF573 ZNF211 ZNF266 ZNF658 ZNF180 ZNF780B ZNF184 ZNF267 ZNF208 ZNF225 ZNF226 ZNF227 ZNF519 ZNF235 ZNF442 ZBTB42 ZNF354C CASZ1 ZNF71 ZNF331 ZNF250 ZNF668 ZNF836 ZNF676 ZFHX4 ZNF544 ZNF43 ZNF540 ZNF197 CIZ1 ZNF727 ZNF480 ZNF770 ZNF766 ZNF528 ZNF107 ZBTB18 ZNF726 ZNF730 ZNF426 ZNF287 ZNF345 | 6.34e-23 | 796 | 176 | 45 | IPR015880 |
| Domain | - | ZNF384 ZNF492 ZNF845 ZNF573 ZNF211 ZNF266 ZNF658 ZNF180 ZNF780B ZNF184 ZNF267 ZNF208 ZNF225 ZNF226 ZNF227 ZNF519 ZNF235 ZNF442 ZBTB42 ZNF354C ZNF71 ZNF331 ZNF250 ZNF668 ZNF836 ZNF676 ZFHX4 ZNF544 ZNF43 ZNF540 ZNF197 ZNF727 ZNF480 ZNF770 ZNF766 ZNF528 ZNF107 ZBTB18 ZNF726 ZNF730 ZNF426 ZNF345 | 7.42e-23 | 679 | 176 | 42 | 3.30.160.60 |
| Domain | KRAB | ZNF492 ZNF845 ZNF573 ZNF211 ZNF658 ZNF180 ZNF780B ZNF184 ZNF267 ZNF208 ZNF225 ZNF226 ZNF227 ZNF519 ZNF235 ZNF442 ZNF354C ZNF331 ZNF250 ZNF836 ZNF544 ZNF43 ZNF540 ZNF197 ZNF727 ZNF480 ZNF766 ZNF528 ZNF726 ZNF730 ZNF426 ZNF287 | 3.12e-22 | 358 | 176 | 32 | PF01352 |
| Domain | IGc2 | IL12B FLT1 FLT4 CEACAM5 OBSCN NCAM2 DSCAML1 LRIG2 IGSF10 LRIG3 HMCN1 NEGR1 NTM IL1RL1 KIT | 6.65e-09 | 235 | 176 | 15 | SM00408 |
| Domain | Ig_sub2 | IL12B FLT1 FLT4 CEACAM5 OBSCN NCAM2 DSCAML1 LRIG2 IGSF10 LRIG3 HMCN1 NEGR1 NTM IL1RL1 KIT | 6.65e-09 | 235 | 176 | 15 | IPR003598 |
| Domain | Ig_I-set | FLT1 FLT4 CEACAM5 OBSCN NCAM2 DSCAML1 LRIG2 IGSF10 LRIG3 HMCN1 NEGR1 NTM IL1RL1 | 3.09e-08 | 190 | 176 | 13 | IPR013098 |
| Domain | I-set | FLT1 FLT4 CEACAM5 OBSCN NCAM2 DSCAML1 LRIG2 IGSF10 LRIG3 HMCN1 NEGR1 NTM IL1RL1 | 3.09e-08 | 190 | 176 | 13 | PF07679 |
| Domain | ig | FLT1 FLT4 CEACAM5 ICAM3 OBSCN NCAM2 IL1RL2 DSCAML1 LRIG2 HMCN1 NEGR1 NTM KIT | 3.09e-08 | 190 | 176 | 13 | PF00047 |
| Domain | Immunoglobulin | FLT1 FLT4 CEACAM5 ICAM3 OBSCN NCAM2 IL1RL2 DSCAML1 LRIG2 HMCN1 NEGR1 NTM KIT | 3.09e-08 | 190 | 176 | 13 | IPR013151 |
| Domain | IG_LIKE | IL12B FLT1 FLT4 CEACAM5 ICAM3 OBSCN NCAM2 IL18RAP IL1RL2 DSCAML1 LRIG2 IGSF10 LRIG3 HMCN1 NEGR1 IGHG2 NTM SCN2B IL1RL1 KIT | 4.16e-08 | 491 | 176 | 20 | PS50835 |
| Domain | Ig-like_fold | IL12B FLT1 FLT4 CEACAM5 ICAM3 OBSCN NCAM2 IL18RAP IL1RL2 DSCAML1 LRIG2 IGSF10 LRIG3 PTPRB HMCN1 NFATC3 NEGR1 IGHG2 NTM SCN2B IL1RL1 ADGRF3 KIT IL7R | 5.31e-08 | 706 | 176 | 24 | IPR013783 |
| Domain | Ig-like_dom | IL12B FLT1 FLT4 CEACAM5 ICAM3 OBSCN NCAM2 IL18RAP IL1RL2 DSCAML1 LRIG2 IGSF10 LRIG3 HMCN1 NEGR1 IGHG2 NTM SCN2B IL1RL1 KIT | 6.18e-08 | 503 | 176 | 20 | IPR007110 |
| Domain | IG | FLT1 FLT4 CEACAM5 ICAM3 OBSCN NCAM2 IL18RAP IL1RL2 DSCAML1 LRIG2 IGSF10 LRIG3 HMCN1 NEGR1 NTM SCN2B IL1RL1 KIT | 1.01e-07 | 421 | 176 | 18 | SM00409 |
| Domain | Ig_sub | FLT1 FLT4 CEACAM5 ICAM3 OBSCN NCAM2 IL18RAP IL1RL2 DSCAML1 LRIG2 IGSF10 LRIG3 HMCN1 NEGR1 NTM SCN2B IL1RL1 KIT | 1.01e-07 | 421 | 176 | 18 | IPR003599 |
| Domain | - | IL12B FLT1 FLT4 CEACAM5 ICAM3 OBSCN NCAM2 IL18RAP IL1RL2 DSCAML1 LRIG2 IGSF10 LRIG3 PTPRB HMCN1 NFATC3 NEGR1 NTM SCN2B IL1RL1 KIT IL7R | 3.03e-07 | 663 | 176 | 22 | 2.60.40.10 |
| Domain | Tyr_kinase_rcpt_3_CS | 4.45e-05 | 8 | 176 | 3 | IPR001824 | |
| Domain | RECEPTOR_TYR_KIN_III | 4.45e-05 | 8 | 176 | 3 | PS00240 | |
| Domain | WD_REPEATS_1 | DMXL2 DCAF4L2 WDR7 DTL RFWD3 NBAS NWD2 DAW1 CSTF1 TAF5L TAF5 | 6.82e-05 | 278 | 176 | 11 | PS00678 |
| Domain | WD_REPEATS_2 | DMXL2 DCAF4L2 WDR7 DTL RFWD3 NBAS NWD2 DAW1 CSTF1 TAF5L TAF5 | 7.04e-05 | 279 | 176 | 11 | PS50082 |
| Domain | WD_REPEATS_REGION | DMXL2 DCAF4L2 WDR7 DTL RFWD3 NBAS NWD2 DAW1 CSTF1 TAF5L TAF5 | 7.04e-05 | 279 | 176 | 11 | PS50294 |
| Domain | IGv | 7.56e-05 | 75 | 176 | 6 | SM00406 | |
| Domain | TFIID_NTD2 | 8.83e-05 | 2 | 176 | 2 | IPR007582 | |
| Domain | TFIID_NTD2 | 8.83e-05 | 2 | 176 | 2 | PF04494 | |
| Domain | IL-1_rcpt_fam | 1.28e-04 | 11 | 176 | 3 | IPR015621 | |
| Domain | WD40 | 2.35e-04 | 268 | 176 | 10 | SM00320 | |
| Domain | WD40_repeat | 2.65e-04 | 272 | 176 | 10 | IPR001680 | |
| Domain | - | DMXL2 DCAF4L2 WDR7 DTL RFWD3 NBAS NWD2 DAW1 CSTF1 TAF5L TAF5 | 3.29e-04 | 333 | 176 | 11 | 2.130.10.10 |
| Domain | WD40/YVTN_repeat-like_dom | DMXL2 DCAF4L2 WDR7 DTL RFWD3 NBAS NWD2 DAW1 CSTF1 TAF5L TAF5 | 3.46e-04 | 335 | 176 | 11 | IPR015943 |
| Domain | - | 5.08e-04 | 17 | 176 | 3 | 4.10.800.10 | |
| Domain | Thyroglobulin_1 | 5.08e-04 | 17 | 176 | 3 | IPR000716 | |
| Domain | THYROGLOBULIN_1_1 | 5.08e-04 | 17 | 176 | 3 | PS00484 | |
| Domain | TY | 5.08e-04 | 17 | 176 | 3 | SM00211 | |
| Domain | THYROGLOBULIN_1_2 | 5.08e-04 | 17 | 176 | 3 | PS51162 | |
| Domain | Thyroglobulin_1 | 5.08e-04 | 17 | 176 | 3 | PF00086 | |
| Domain | Neural_cell_adh | 5.23e-04 | 4 | 176 | 2 | IPR009138 | |
| Domain | WD40_repeat_dom | 5.29e-04 | 297 | 176 | 10 | IPR017986 | |
| Domain | Ig_V-set | 6.10e-04 | 199 | 176 | 8 | IPR013106 | |
| Domain | WD40 | 8.02e-04 | 259 | 176 | 9 | PF00400 | |
| Domain | WD40_repeat_CS | 9.42e-04 | 164 | 176 | 7 | IPR019775 | |
| Domain | TIR | 9.66e-04 | 21 | 176 | 3 | SM00255 | |
| Domain | TIR | 1.11e-03 | 22 | 176 | 3 | PF01582 | |
| Domain | - | 1.27e-03 | 23 | 176 | 3 | 3.40.50.10140 | |
| Domain | IL-1_rcpt_I/II-typ | 1.29e-03 | 6 | 176 | 2 | IPR004074 | |
| Domain | TIR | 1.44e-03 | 24 | 176 | 3 | PS50104 | |
| Domain | TIR_dom | 1.62e-03 | 25 | 176 | 3 | IPR000157 | |
| Domain | PROTEIN_KINASE_TYR | 2.25e-03 | 97 | 176 | 5 | PS00109 | |
| Domain | Tyr_kinase_AS | 2.25e-03 | 97 | 176 | 5 | IPR008266 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION | ZNF492 ZNF573 ZNF211 ZNF266 ZNF658 RBL1 CNOT10 ZNF180 ZNF184 ZNF267 ZNF208 ZNF225 ZNF226 ZNF227 RET ZNF519 ZNF235 ZNF442 ZNF354C ZNF71 ZNF331 CNOT6 PCF11 ZNF250 PPARGC1A PARP1 ZNF668 ZNF676 PBRM1 IGFBP1 ZNF544 ZNF43 ZNF540 ZNF197 ZNF724 CSTF1 ZNF727 ZNF480 ZNF770 ZNF528 PIP4K2C TAF5 KIT ZNF726 ZNF730 ZNF426 ZNF287 COL1A1 COL1A2 | 1.65e-16 | 1387 | 137 | 49 | M734 |
| Pathway | REACTOME_GENERIC_TRANSCRIPTION_PATHWAY | ZNF845 RBL1 CNOT10 ZNF180 ZNF780B ZNF184 ZNF267 ZNF208 ZNF226 ZNF519 ZNF235 ZNF442 ZNF354C CNOT6 ZNF250 PARP1 ZNF836 PBRM1 ZNF43 ZNF727 ZNF770 PIP4K2C TAF5 ZNF107 ZNF726 ZNF426 | 2.02e-08 | 768 | 137 | 26 | MM14851 |
| Pathway | REACTOME_GENE_EXPRESSION_TRANSCRIPTION | ZNF845 RBL1 CNOT10 ZNF180 ZNF780B ZNF184 ZNF267 ZNF208 ZNF226 ZNF519 ZNF235 ZNF442 ZNF354C CNOT6 PCF11 ZNF250 PARP1 ZNF836 PBRM1 PHF20L1 ZNF43 RRN3 CSTF1 ZNF727 ZNF770 PIP4K2C TAF5 ZNF107 ZNF726 ZNF426 | 3.50e-08 | 1022 | 137 | 30 | MM15436 |
| Pubmed | ZNF845 ZNF211 ZNF184 RANBP9 ZNF267 ZNF208 ZNF227 ZNF235 ZNF250 ZNF197 ZNF724 ZNF480 ZNF766 ZNF107 ZNF726 | 4.51e-14 | 181 | 181 | 15 | 37372979 | |
| Pubmed | Rapid and efficient cloning of cDNAs encoding Krüppel-like zinc finger proteins by degenerate PCR. | 6.57e-09 | 49 | 181 | 7 | 9630514 | |
| Pubmed | FLT1 CEACAM5 OBSCN NCAM2 DSCAML1 LRIG2 IGSF10 HMCN1 NEGR1 NTM | 1.48e-08 | 162 | 181 | 10 | 25826454 | |
| Pubmed | 5.26e-08 | 20 | 181 | 5 | 12743021 | ||
| Pubmed | 6.87e-08 | 21 | 181 | 5 | 7865130 | ||
| Pubmed | 1.76e-07 | 25 | 181 | 5 | 19180518 | ||
| Pubmed | 3.88e-07 | 29 | 181 | 5 | 14563677 | ||
| Pubmed | 4.89e-07 | 13 | 181 | 4 | 19850934 | ||
| Pubmed | Rev1 contributes to proper mitochondrial function via the PARP-NAD+-SIRT1-PGC1α axis. | 5.52e-07 | 4 | 181 | 3 | 28970491 | |
| Pubmed | 9.26e-07 | 15 | 181 | 4 | 15885501 | ||
| Pubmed | 1.38e-06 | 5 | 181 | 3 | 18211825 | ||
| Pubmed | Coronary development is regulated by ATP-dependent SWI/SNF chromatin remodeling component BAF180. | 3.96e-06 | 21 | 181 | 4 | 18508041 | |
| Pubmed | ZNF780B RANBP9 ZNF235 PARP1 OSBP ZNF836 ZNF540 ZNF766 ZNF107 ZNF726 COL1A1 COL1A2 | 4.83e-06 | 451 | 181 | 12 | 36168627 | |
| Pubmed | Allelic variants of IL1R1 gene associate with severe hand osteoarthritis. | 1.14e-05 | 9 | 181 | 3 | 20353565 | |
| Pubmed | 1.14e-05 | 9 | 181 | 3 | 19881219 | ||
| Pubmed | Common genetic variation at the IL1RL1 locus regulates IL-33/ST2 signaling. | 1.14e-05 | 9 | 181 | 3 | 23999434 | |
| Pubmed | A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome. | FLT4 ZNF573 RET PPM1B PARP1 EYS PTPRB MTMR3 KIT COL1A1 COL1A2 | 1.40e-05 | 420 | 181 | 11 | 28065597 |
| Pubmed | Structural basis for endosomal trafficking of diverse transmembrane cargos by PX-FERM proteins. | 1.54e-05 | 101 | 181 | 6 | 23382219 | |
| Pubmed | Functional analysis of the SRY-KRAB interaction in mouse sex determination. | 1.62e-05 | 10 | 181 | 3 | 18588511 | |
| Pubmed | Sry associates with the heterochromatin protein 1 complex by interacting with a KRAB domain protein. | 2.22e-05 | 11 | 181 | 3 | 15469996 | |
| Pubmed | ZNF180 ZNF208 ZNF235 ZNF354C IBTK ZNF668 ZNF836 CPHXL PBRM1 PHF20L1 ZNF43 CIZ1 MAEL ZNF726 ZNF426 | 2.38e-05 | 808 | 181 | 15 | 20412781 | |
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 32335875 | ||
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 19064815 | ||
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 5529814 | ||
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 28368336 | ||
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 9443882 | ||
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 15241796 | ||
| Pubmed | Regional chromosome mapping of human collagen genes alpha 2(I) and alpha 1(I) (COLIA2 and COLIA1). | 2.69e-05 | 2 | 181 | 2 | 3857213 | |
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 31876392 | ||
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 23692737 | ||
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 32091183 | ||
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 17393120 | ||
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 20139274 | ||
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 10608859 | ||
| Pubmed | Mutations in type I collagen genes in Japanese osteogenesis imperfecta patients. | 2.69e-05 | 2 | 181 | 2 | 17875077 | |
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 19714363 | ||
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 21602843 | ||
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 34727246 | ||
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 26927310 | ||
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 22555639 | ||
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 32166892 | ||
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 23075886 | ||
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 21193410 | ||
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 27090748 | ||
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 6857446 | ||
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 17289816 | ||
| Pubmed | Prognostic significance of LRIG2 and LRIG3 proteins in urothelial bladder carcinoma. | 2.69e-05 | 2 | 181 | 2 | 34839782 | |
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 22325288 | ||
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 27748872 | ||
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 7629088 | ||
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 20142273 | ||
| Pubmed | Nmp4/CIZ suppresses parathyroid hormone-induced increases in trabecular bone. | 2.69e-05 | 2 | 181 | 2 | 19189321 | |
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 11358497 | ||
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 11143996 | ||
| Pubmed | [Analysis of COL1A1 and COL1A2 gene variants in two fetuses with osteogenesis imperfecta]. | 2.69e-05 | 2 | 181 | 2 | 37368383 | |
| Pubmed | Osteogenesis imperfecta: comparison of molecular defects with bone histological changes. | 2.69e-05 | 2 | 181 | 2 | 7520724 | |
| Pubmed | Prenatal Cases Reflect the Complexity of the COL1A1/2 Associated Osteogenesis Imperfecta. | 2.69e-05 | 2 | 181 | 2 | 36140746 | |
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 7945553 | ||
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 28219892 | ||
| Pubmed | Early type I collagen deposition is associated with prognosis in biliary atresia. | 2.69e-05 | 2 | 181 | 2 | 26452701 | |
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 8097422 | ||
| Pubmed | Oxidative status of muscle is determined by p107 regulation of PGC-1alpha. | 2.69e-05 | 2 | 181 | 2 | 20713602 | |
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 19469869 | ||
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 28498836 | ||
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 28981938 | ||
| Pubmed | Angiopoietin-2 promotes myeloid cell infiltration in a β₂-integrin-dependent manner. | 2.69e-05 | 2 | 181 | 2 | 21868579 | |
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 35332328 | ||
| Pubmed | Mutational analysis of COL1A1 and COL1A2 genes among Estonian osteogenesis imperfecta patients. | 2.69e-05 | 2 | 181 | 2 | 28810924 | |
| Pubmed | Structural basis of homo- and heterotrimerization of collagen I. | 2.69e-05 | 2 | 181 | 2 | 28281531 | |
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 10408781 | ||
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 2777764 | ||
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 36639372 | ||
| Pubmed | Biochemical markers of bone turnover and clinical outcomes in men with prostate cancer. | 2.69e-05 | 2 | 181 | 2 | 21163673 | |
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 19929435 | ||
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 28528406 | ||
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 30604926 | ||
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 32710982 | ||
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 31794058 | ||
| Pubmed | COL1A1 and COL1A2 variants in Ehlers-Danlos syndrome phenotypes and COL1-related overlap disorder. | 2.69e-05 | 2 | 181 | 2 | 36896471 | |
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 35688666 | ||
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 25262119 | ||
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 15085313 | ||
| Pubmed | Osteogenesis imperfecta: translation of mutation to phenotype. | 2.69e-05 | 2 | 181 | 2 | 1895312 | |
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 18375391 | ||
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 15203213 | ||
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 8393164 | ||
| Pubmed | Unequal Impact of COL1A1 and COL1A2 Variants on Dentinogenesis Imperfecta. | 2.69e-05 | 2 | 181 | 2 | 36951356 | |
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 17211858 | ||
| Pubmed | Mutation spectrum of COL1A1 and COL1A2 genes in Indian patients with osteogenesis imperfecta. | 2.69e-05 | 2 | 181 | 2 | 24668929 | |
| Pubmed | [Relationship of collagen type I alpha 1 and alpha 2 gene polymorphisms with bone mineral density]. | 2.69e-05 | 2 | 181 | 2 | 16864092 | |
| Pubmed | Evidence for a relationship between Ehlers-Danlos type VII C in humans and bovine dermatosparaxis. | 2.69e-05 | 2 | 181 | 2 | 1303238 | |
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 1874719 | ||
| Pubmed | Differential unfolding of alpha1 and alpha2 chains in type I collagen and collagenolysis. | 2.69e-05 | 2 | 181 | 2 | 18644377 | |
| Pubmed | COL1 C-propeptide cleavage site mutations cause high bone mass osteogenesis imperfecta. | 2.69e-05 | 2 | 181 | 2 | 21344539 | |
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 11668615 | ||
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 35172811 | ||
| Pubmed | Cranial base abnormalities in osteogenesis imperfecta: phenotypic and genotypic determinants. | 2.69e-05 | 2 | 181 | 2 | 20721936 | |
| Pubmed | A cysteine-based molecular code informs collagen C-propeptide assembly. | 2.69e-05 | 2 | 181 | 2 | 30310058 | |
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 21405976 | ||
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 9016532 | ||
| Cytoband | Ensembl 112 genes in cytogenetic band chr19q13 | ZNF845 ZNF573 ZNF211 CEACAM5 ZNF180 ZNF780B ZNF225 ZNF226 ZNF227 ZNF235 ZNF71 ZNF331 ZNF836 CACNG6 ZNF544 ZNF540 ZNF480 ZNF525 ZNF766 ZNF528 ZNF345 | 1.25e-08 | 1192 | 181 | 21 | chr19q13 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p12 | 6.03e-07 | 122 | 181 | 7 | chr19p12 | |
| Cytoband | 19p12 | 1.64e-06 | 90 | 181 | 6 | 19p12 | |
| Cytoband | 2q12 | 1.29e-05 | 12 | 181 | 3 | 2q12 | |
| Cytoband | 19q13.2 | 5.05e-04 | 164 | 181 | 5 | 19q13.2 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF384 ZNF492 ZNF845 ZNF573 ZNF211 ZNF266 ZNF658 ZNF180 ZNF780B ZNF184 ZNF267 ZNF208 ZNF225 ZNF226 ZNF227 ZNF519 ZNF235 ZNF442 ZBTB42 ZNF354C CASZ1 ZNF71 ZNF331 ZNF250 ZNF668 ZNF836 ZNF676 ZNF544 ZNF43 ZNF540 ZNF197 ZNF727 ZNF480 ZNF525 ZNF770 ZNF766 ZNF528 ZNF107 ZBTB18 ZNF726 ZNF730 ZNF426 ZNF287 ZNF345 | 1.23e-27 | 718 | 141 | 44 | 28 |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | FLT1 FLT4 CEACAM5 OBSCN NCAM2 DSCAML1 LRIG2 IGSF10 LRIG3 HMCN1 NEGR1 NTM IL1RL1 | 4.02e-10 | 161 | 141 | 13 | 593 |
| GeneFamily | Immunoglobulin like domain containing | IL12B FLT1 FLT4 CEACAM5 ICAM3 IL18RAP IL1RL2 DSCAML1 IL1RL1 KIT | 2.80e-06 | 193 | 141 | 10 | 594 |
| GeneFamily | CD molecules|I-set domain containing|Immunoglobulin like domain containing|Interleukin receptors|TIR domain containing | 1.97e-04 | 15 | 141 | 3 | 1296 | |
| GeneFamily | WD repeat domain containing | 2.18e-04 | 262 | 141 | 9 | 362 | |
| GeneFamily | Receptor Tyrosine Kinases|CD molecules | 2.60e-04 | 40 | 141 | 4 | 321 | |
| GeneFamily | CD molecules|I-set domain containing|Immunoglobulin like domain containing|Interleukin receptors|TIR domain containing | 3.15e-04 | 42 | 141 | 4 | 602 | |
| GeneFamily | I-set domain containing|IgLON cell adhesion molecules | 5.95e-04 | 5 | 141 | 2 | 1052 | |
| GeneFamily | CCR4-NOT transcription complex | 3.17e-03 | 11 | 141 | 2 | 1023 | |
| Coexpression | GSE2706_UNSTIM_VS_2H_LPS_AND_R848_DC_UP | ZNF211 ZNF184 ZNF227 RFWD3 ZNF250 MTMR3 CSTF1 ZNF770 ZNF766 TAF5 | 9.17e-07 | 191 | 181 | 10 | M4702 |
| Coexpression | CADWELL_ATG16L1_TARGETS_DN | 1.25e-05 | 74 | 181 | 6 | MM768 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.11e-07 | 195 | 181 | 9 | b65463a804fed2d9a3be9e528ca8b9c98469bc86 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.11e-07 | 195 | 181 | 9 | cec7df321f372d05c94f97d6bb18891a5cc3dec3 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.16e-07 | 196 | 181 | 9 | df366d76ea55f49e349d622effa57c1535df8400 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Serous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | BHLHE41 MCC SLC1A2 CASZ1 ADGRG6 LRIG3 PPARGC1A ELAPOR1 CYP4X1 | 1.37e-07 | 200 | 181 | 9 | 030efc36bbb848da31b0db3f74d46aac9c79cc9b |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-myeloid_dendritic_cell-Ccr7+_dendritic|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.15e-07 | 175 | 181 | 8 | 1b910c08d2bfbcc77431ee66103e63a11a9d39fe | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-T_cells-LTi-like_NCR+_ILC3|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.00e-07 | 178 | 181 | 8 | 0b59e3d75b143bd7bf91a7800a49699c51e68c5a | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Hematopoietic-T_cells-ILCP|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.30e-07 | 179 | 181 | 8 | dd3cf8fd10dc257d933a7f45860dc2e244c158b7 | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0|368C / Donor, Lineage, Cell class and subclass (all cells) | 8.98e-07 | 184 | 181 | 8 | d48807f9da48bdd015a54c606d2e2a311f181396 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 9.74e-07 | 186 | 181 | 8 | 8915436d09775f2828a7678af203b1082b36e21c | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Ascending_Thin_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.17e-06 | 132 | 181 | 7 | 97e7d5f7086c6213aec4eaa581bc182338189029 | |
| ToppCell | ASK440-Mesenchymal|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.19e-06 | 191 | 181 | 8 | f12959eebb4167e1aa03de05d7711a702c58b3c9 | |
| ToppCell | ASK440-Mesenchymal-Fibroblast|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.19e-06 | 191 | 181 | 8 | 387296b5377ef6839f0812e5b3529a10b5f7d530 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Scavenging_endothelial|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.34e-06 | 194 | 181 | 8 | cceb7c88492bb6cd531e1c2651638da1ddf30931 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Scavenging_endothelial-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.34e-06 | 194 | 181 | 8 | ea5e1bc8d9e27cabfe1fb833ca47ec0893593b12 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D122|Adult / Lineage, Cell type, age group and donor | 1.39e-06 | 195 | 181 | 8 | aa0add081881d349099d12efca5cdee098038d4e | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.39e-06 | 195 | 181 | 8 | df409f94f4e83be89f7a608058ee07ce3ce3a149 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.39e-06 | 195 | 181 | 8 | 4243190ad291d56694e2155954dbaa879c9d3844 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.44e-06 | 196 | 181 | 8 | 42e9828222a9663525d571633e8a454c30bfa7f8 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_mature-Endo_capilar|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.50e-06 | 197 | 181 | 8 | e567f91fa398fd306d025dcfe89bd50a60216537 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_fibro-stroma-arteriolar_fibroblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.68e-06 | 200 | 181 | 8 | fee22a6a6c7b93af204b5b56f2c34f1411500e18 | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_D2|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.42e-06 | 155 | 181 | 7 | 216a240bfb82cdefc59e2f342689dbaaacb7c184 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.42e-06 | 155 | 181 | 7 | 77fdae85d36efb776db977eb424b32487ef222e4 | |
| ToppCell | 3'_v3-blood-Lymphocytic_Invariant-Inducer-like-ILC3|blood / Manually curated celltypes from each tissue | 3.72e-06 | 157 | 181 | 7 | eb2520c237543ea4869d4386afc0457b111f6193 | |
| ToppCell | 5'-Adult-SmallIntestine-Hematopoietic-T_cells-MAIT_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.96e-06 | 164 | 181 | 7 | aff5138b35a06b0819e52855744797bfa343633a | |
| ToppCell | Control-Lymphocyte-T_NK-MAIT|Control / Disease, Lineage and Cell Type | 6.04e-06 | 169 | 181 | 7 | 8c2aac193a9c500f01a99a2ee530839c851b6222 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_mature-Endo_capilar-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.78e-06 | 172 | 181 | 7 | c3a99828838af3b85c8c885d69cc8018f55ced50 | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-Ccr7+_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.32e-06 | 174 | 181 | 7 | 7be0c6248e77f2d0260b852b01e17892f7828f1b | |
| ToppCell | -IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 7.32e-06 | 174 | 181 | 7 | ba50cc04fcdee1926d4af4787ac86555ae9632cc | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 7.59e-06 | 175 | 181 | 7 | ff0789f5913c9f3c49159e40b1ec3d2ff175ec9f | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_NK-T_mait-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 7.59e-06 | 175 | 181 | 7 | cc2428150987911d0d382e8177918724aa69f85c | |
| ToppCell | P03-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.59e-06 | 175 | 181 | 7 | 282f09bbdfa70d93b3f66591dcfb84c5ee0268c7 | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN1(Slc17a7)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 7.59e-06 | 175 | 181 | 7 | 21f8f11a8b874d4f7c47931010a2535f2a5a3373 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_NK-T_mait|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 7.88e-06 | 176 | 181 | 7 | 003076f1a983409ddf31b9c19e61c1facdd72566 | |
| ToppCell | droplet-Liver-hepatocytes-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.18e-06 | 177 | 181 | 7 | 8ef41ee5d63737b810ad7371b0437625e7e1badf | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Hematopoietic-T_cells|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.80e-06 | 179 | 181 | 7 | e717c0079b788a3703c0a450922bd5a2bdc322a0 | |
| ToppCell | normal-na-Lymphocytic_NK-T_mait-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 9.13e-06 | 180 | 181 | 7 | e66a8a61b3576ac37de7c559d16d4ed4f7a2fc78 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.46e-06 | 181 | 181 | 7 | 9ede19228ba5c0668a9c06c915510b95585216ef | |
| ToppCell | LV-17._Lymphocyte|LV / Chamber and Cluster_Paper | 9.46e-06 | 181 | 181 | 7 | 81fafa69c8c240250a667a5f3b321e8be1b9a288 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.81e-06 | 182 | 181 | 7 | 5e1b316599436740f1b30875f0ebd33c3edfb2b6 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-05 | 184 | 181 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-05 | 184 | 181 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 1.05e-05 | 184 | 181 | 7 | 67164bb6bcae7322cb89b585c7aa10bce35b0ecd | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-05 | 184 | 181 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.09e-05 | 185 | 181 | 7 | e1fbec55b71f604189eb2431768fadbaa0453a83 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.09e-05 | 185 | 181 | 7 | 9d933cd5ebc8368fd37aa83113d2dfa6938ff72d | |
| ToppCell | Healthy-multiplets|Healthy / disease group, cell group and cell class | 1.13e-05 | 186 | 181 | 7 | 2ec999b97e95afb898f8083042b0f188d3d234bc | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.13e-05 | 186 | 181 | 7 | a906020a8df6fcca474b278f746c553b177a56b4 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-05 | 188 | 181 | 7 | 1efbc99bcd6542e5d9fa91edb7c4295167914786 | |
| ToppCell | Adult|World / Lineage, Cell type, age group and donor | 1.25e-05 | 189 | 181 | 7 | 5cd285bfad973125d46d704fec18b21266a63379 | |
| ToppCell | IPF-Myeloid-DC_Mature|Myeloid / Disease state, Lineage and Cell class | 1.25e-05 | 189 | 181 | 7 | 49e67d298d045f29136919b7d9971b6502b0efaa | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma-1|TCGA-Brain / Sample_Type by Project: Shred V9 | 1.29e-05 | 126 | 181 | 6 | 8b689886ce35ff798aea603cde9ccb0dc9d1fd03 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.30e-05 | 190 | 181 | 7 | a3c6eec6df052105ab78b7e3c78f94218d5912eb | |
| ToppCell | wk_20-22-Hematologic_Lymphocytic-T_&_ILC-NKT1|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.30e-05 | 190 | 181 | 7 | 326002d7f9de5e425cee76d9a0277f42d79058e2 | |
| ToppCell | COPD-Myeloid-DC_Mature|Myeloid / Disease state, Lineage and Cell class | 1.39e-05 | 192 | 181 | 7 | baebd462f464e7d0e462d07a74bb5d685a9fc3b6 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Hematopoietic-T_cells-Activated_T|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.48e-05 | 194 | 181 | 7 | e3705346755cbf65fc276d4d4fbee936ed6bb7bf | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Hematopoietic-T_cells-Activated_T|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.48e-05 | 194 | 181 | 7 | 6385cf2a1529d2e225e407c33da959fccaaca3a4 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.53e-05 | 195 | 181 | 7 | 56d8734d020b3da08a5aa9e67999706a9e023a99 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_mature-Endo_capilar-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.59e-05 | 196 | 181 | 7 | 889c9fed857f64664ca1f47fcec9fecb15ed103c | |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.59e-05 | 196 | 181 | 7 | bc94909f9b2dc08a59eef1914148b69720569c8f | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.59e-05 | 196 | 181 | 7 | 3f065139f76ed048875cd6c03aa02300db2b6574 | |
| ToppCell | normal_Lung-Fibroblasts-COL13A1+_matrix_FBs|normal_Lung / Location, Cell class and cell subclass | 1.64e-05 | 197 | 181 | 7 | 6c57ab2efb8363828e24211c4d45e58bb73a9a4d | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.64e-05 | 197 | 181 | 7 | 13896ec65ccda0b928c91d41112dc01b480036b7 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.64e-05 | 197 | 181 | 7 | 1485933986921ff45669d9b7501c8d17050b3e97 | |
| ToppCell | Sepsis-URO-Lymphocyte-T/NK-MAIT|URO / Disease, condition lineage and cell class | 1.69e-05 | 198 | 181 | 7 | 75db638278d4be2b0f406cd8871058a8352c5a86 | |
| ToppCell | Sepsis-Bac-SEP-Lymphocyte-T/NK-MAIT|Bac-SEP / Disease, condition lineage and cell class | 1.69e-05 | 198 | 181 | 7 | aea3654b16785aa9857ed646bd0d0dc9724df364 | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.69e-05 | 198 | 181 | 7 | f1374f7a50244d59c766ac41f44c08c9117407d2 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_capilar-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.75e-05 | 199 | 181 | 7 | 236b1417ed0875e98c6ec1ec714003bfce438d65 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_fibro-stroma-arteriolar_fibroblast|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.75e-05 | 199 | 181 | 7 | 95d95e9b7bd3933188998ae94986213eb0f1e5ea | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Macrophage_other-Macrophage_intermediate|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.75e-05 | 199 | 181 | 7 | ccd473accf2205c120c0d32031619e421558a861 | |
| ToppCell | Bronchial-10x5prime-Stromal-Peri/Epineurial_|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.75e-05 | 199 | 181 | 7 | 45c3b853900d8c3d5965117d904e3714100138bc | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Vein|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.75e-05 | 199 | 181 | 7 | cfb624c7728046fc7f3ef071f57e4d7b013f3fef | |
| ToppCell | Control_saline-Endothelial-Endothelial-Vein|Control_saline / Treatment groups by lineage, cell group, cell type | 1.81e-05 | 200 | 181 | 7 | e5f876910bc8cb390d9b46a48d9b6d4d57235551 | |
| ToppCell | Bronchus_Control_(B.)-Stromal-TX-Fibroblasts-2,_SCARA5|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 1.81e-05 | 200 | 181 | 7 | 2022df85df94ab8cbb4e80e3fe9894c01051c5e0 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(PCT)|kidney / Disease (COVID-19 only), tissue and cell type | 2.97e-05 | 146 | 181 | 6 | c55f1bdb6ac43b4118cb27ea7c879527e1afcbab | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|368C / Donor, Lineage, Cell class and subclass (all cells) | 3.08e-05 | 147 | 181 | 6 | 3ed5b020ce1f1277917d79ef1f7da53fa474e8db | |
| ToppCell | 3'_v3-blood-Lymphocytic_Invariant-Inducer-like|blood / Manually curated celltypes from each tissue | 3.33e-05 | 149 | 181 | 6 | 75422e1a22736375e9ef439db0b2a5efa3f653a3 | |
| ToppCell | Int-URO-Lymphocyte-T_NK-CD8_Naive|Int-URO / Disease, Lineage and Cell Type | 3.72e-05 | 152 | 181 | 6 | 52d6f9cf1f4637c922f582705d625b4cbe3dc0c2 | |
| ToppCell | 5'-Adult-Appendix-Epithelial-Tuft-related-Tuft|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.30e-05 | 156 | 181 | 6 | 58b9520fce6e259b36c3d59e82b712f5e7729e3e | |
| ToppCell | severe_COVID-19-cDC|World / disease group, cell group and cell class (v2) | 4.30e-05 | 156 | 181 | 6 | 0a7e18ed8e13261c405eb6b9a183e99d8e1aac37 | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_E|343B / Donor, Lineage, Cell class and subclass (all cells) | 4.46e-05 | 157 | 181 | 6 | 0362c04b7b0b5017964b3a73ee678ae53e7238d7 | |
| ToppCell | severe_COVID-19-cDC|severe_COVID-19 / disease group, cell group and cell class (v2) | 4.46e-05 | 157 | 181 | 6 | ec1978e07e2214048d015d8bb793c1d9991f6e37 | |
| ToppCell | severe-CD4+_T_naive|World / disease stage, cell group and cell class | 4.46e-05 | 157 | 181 | 6 | ccf9abe0b59e9ea728cec4bba1872ffe14c7385c | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1.5|368C / Donor, Lineage, Cell class and subclass (all cells) | 4.62e-05 | 158 | 181 | 6 | 390b9c455ed15a6804613eecfd2776949dfba146 | |
| ToppCell | Bac-SEP-Lymphocyte-T_NK-MAIT|Bac-SEP / Disease, Lineage and Cell Type | 4.78e-05 | 159 | 181 | 6 | e043c65f3febdfa7f75a67702e92fcdebe144a00 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.78e-05 | 159 | 181 | 6 | 7ed659163f45e0c4df4782997c0786900c8186c8 | |
| ToppCell | Severe-Lymphoid-NK-Proliferating_T|Severe / Condition, Lineage, Cell class and cell subclass | 4.95e-05 | 160 | 181 | 6 | cb2276d9bd78508644420e9580d3c17b914224cb | |
| ToppCell | NS-critical-LOC-Myeloid-Basophil|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.95e-05 | 160 | 181 | 6 | 8a4746463ca1976f7d6de803496c851249ced797 | |
| ToppCell | URO-Lymphocyte-T_NK-CD4_TEM|URO / Disease, Lineage and Cell Type | 4.95e-05 | 160 | 181 | 6 | e406f77b1c1a01d74f39ba65f99d5f8c7d75faf1 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.13e-05 | 161 | 181 | 6 | 82ed45f144a07856fe92d37426c5f92e259a03a9 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Hematopoietic-T_cells-ILCP|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.13e-05 | 161 | 181 | 6 | 6d9907e2949a742c0933128fde57832a9ca5f77c | |
| ToppCell | severe_influenza-CD8+_T_naive|severe_influenza / disease group, cell group and cell class (v2) | 5.13e-05 | 161 | 181 | 6 | 82196139cdbbd70a36957a87bc9ac6d02575da3f | |
| ToppCell | facs-Pancreas-Endocrine-18m-Epithelial-pancreatic_PP_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.31e-05 | 162 | 181 | 6 | ca1014e32996f777bff021830ce9a7cf4acf58d5 | |
| ToppCell | Severe-Lymphoid-NK-CCR7+_T|Severe / Condition, Lineage, Cell class and cell subclass | 5.49e-05 | 163 | 181 | 6 | 8f0d8c124f1569a5a6bc1db7581989f24d63cca3 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.68e-05 | 164 | 181 | 6 | a764b79a127c8f360af0b79a1da64658badf0dfa | |
| ToppCell | Mild-Myeloid-Mast|Mild / Condition, Lineage, Cell class and cell subclass | 5.88e-05 | 165 | 181 | 6 | 5fa9552c37890c5cc7e672a47038aebba2413cb4 | |
| ToppCell | Mild-Myeloid-Mast-|Mild / Condition, Lineage, Cell class and cell subclass | 5.88e-05 | 165 | 181 | 6 | 93d3909a0f5f43d473d5005c842d7d73e25eceed | |
| ToppCell | 10x3'2.3-week_14-16-Lymphocytic_NK-T_NK-NK_progenitor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 6.08e-05 | 166 | 181 | 6 | b041010038a570ad929812f35514cb54e4f68f66 | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-CD8+_T-MAIT-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.08e-05 | 166 | 181 | 6 | bb93db4613c067c56614ab1ca39e73ee46484387 | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-CD8+_T-MAIT|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.08e-05 | 166 | 181 | 6 | c1f17a028bb27b8f202bcfffa7de7373b1cdd990 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-Tnaive/CM_CD4_activated|Liver / Manually curated celltypes from each tissue | 6.08e-05 | 166 | 181 | 6 | 9afa33b5ad27dc33576be592f9b22d8161366838 | |
| Drug | SU11652 | 1.19e-06 | 11 | 180 | 4 | CID005329103 | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 2.92e-05 | 148 | 174 | 7 | C0279702 | |
| Disease | interleukin 1 receptor-like 1 measurement | 3.21e-05 | 11 | 174 | 3 | EFO_0008168 | |
| Disease | serum ST2 measurement | 3.21e-05 | 11 | 174 | 3 | EFO_0005416 | |
| Disease | EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE | 3.46e-05 | 2 | 174 | 2 | C0268345 | |
| Disease | EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 1 | 3.46e-05 | 2 | 174 | 2 | C4551623 | |
| Disease | Osteogenesis imperfecta with normal sclerae, dominant form | 3.46e-05 | 2 | 174 | 2 | cv:C0268363 | |
| Disease | Osteogenesis imperfecta type III | 3.46e-05 | 2 | 174 | 2 | cv:C0268362 | |
| Disease | Osteogenesis imperfecta, perinatal lethal | 3.46e-05 | 2 | 174 | 2 | cv:C0268358 | |
| Disease | OSTEOGENESIS IMPERFECTA, TYPE III | 3.46e-05 | 2 | 174 | 2 | 259420 | |
| Disease | osteogenesis imperfecta type 3 (is_implicated_in) | 3.46e-05 | 2 | 174 | 2 | DOID:0110339 (is_implicated_in) | |
| Disease | osteogenesis imperfecta type 4 (is_implicated_in) | 3.46e-05 | 2 | 174 | 2 | DOID:0110340 (is_implicated_in) | |
| Disease | osteogenesis imperfecta type 2 (is_implicated_in) | 3.46e-05 | 2 | 174 | 2 | DOID:0110341 (is_implicated_in) | |
| Disease | OSTEOGENESIS IMPERFECTA, TYPE IV | 3.46e-05 | 2 | 174 | 2 | 166220 | |
| Disease | OSTEOGENESIS IMPERFECTA, TYPE II | 3.46e-05 | 2 | 174 | 2 | 166210 | |
| Disease | thyroid gland carcinoma (is_marker_for) | 4.26e-05 | 12 | 174 | 3 | DOID:3963 (is_marker_for) | |
| Disease | Early Pregnancy Loss | 4.73e-05 | 109 | 174 | 6 | C3830362 | |
| Disease | Spontaneous abortion | 4.73e-05 | 109 | 174 | 6 | C0000786 | |
| Disease | Miscarriage | 4.73e-05 | 109 | 174 | 6 | C4552766 | |
| Disease | Abortion, Tubal | 4.73e-05 | 109 | 174 | 6 | C0000822 | |
| Disease | Testicular Germ Cell Tumor | 6.99e-05 | 14 | 174 | 3 | C1336708 | |
| Disease | Colorectal Carcinoma | TET2 CLSTN3 EFS OBSCN MCC RET ZNF442 DSCAML1 PARP1 OSBP ZNF43 ZNF540 MCM3AP ZNF480 | 7.75e-05 | 702 | 174 | 14 | C0009402 |
| Disease | interleukin 18 receptor 1 measurement | 8.70e-05 | 15 | 174 | 3 | EFO_0008178 | |
| Disease | osteogenesis imperfecta (is_implicated_in) | 1.03e-04 | 3 | 174 | 2 | DOID:12347 (is_implicated_in) | |
| Disease | osteogenesis imperfecta type 3 (implicated_via_orthology) | 1.03e-04 | 3 | 174 | 2 | DOID:0110339 (implicated_via_orthology) | |
| Disease | Secondary Biliary Cholangitis | 1.10e-04 | 42 | 174 | 4 | C0238065 | |
| Disease | Biliary cirrhosis | 1.10e-04 | 42 | 174 | 4 | C0023892 | |
| Disease | Biliary Cirrhosis, Primary, 1 | 1.10e-04 | 42 | 174 | 4 | C4551595 | |
| Disease | Sarcomatoid Renal Cell Carcinoma | 1.15e-04 | 128 | 174 | 6 | C1266043 | |
| Disease | Chromophobe Renal Cell Carcinoma | 1.15e-04 | 128 | 174 | 6 | C1266042 | |
| Disease | Collecting Duct Carcinoma of the Kidney | 1.15e-04 | 128 | 174 | 6 | C1266044 | |
| Disease | Papillary Renal Cell Carcinoma | 1.15e-04 | 128 | 174 | 6 | C1306837 | |
| Disease | Renal Cell Carcinoma | 1.15e-04 | 128 | 174 | 6 | C0007134 | |
| Disease | FEV/FEC ratio | TET2 FLT1 ABR ZNF184 MCC ACVR1 ZBTB42 SLC1A2 ZNF354C PPM1B ADGRG6 TG PPARGC1A HMCN1 NEGR1 NTM MTMR3 IL1RL1 IL7R | 1.25e-04 | 1228 | 174 | 19 | EFO_0004713 |
| Disease | rhinitis | 1.29e-04 | 17 | 174 | 3 | EFO_0008521 | |
| Disease | Hemangiosarcoma | 1.54e-04 | 18 | 174 | 3 | C0018923 | |
| Disease | Primary biliary cirrhosis | 1.71e-04 | 47 | 174 | 4 | C0008312 | |
| Disease | cancer (implicated_via_orthology) | 2.02e-04 | 268 | 174 | 8 | DOID:162 (implicated_via_orthology) | |
| Disease | Systemic mastocytosis with associated clonal, hematologic non-mast-cell lineage disease | 2.06e-04 | 4 | 174 | 2 | C1301365 | |
| Disease | cutaneous leishmaniasis (is_implicated_in) | 2.06e-04 | 4 | 174 | 2 | DOID:9111 (is_implicated_in) | |
| Disease | Transitional cell carcinoma of bladder | 2.06e-04 | 4 | 174 | 2 | C0279680 | |
| Disease | OSTEOPOROSIS | 2.06e-04 | 4 | 174 | 2 | 166710 | |
| Disease | ST2 protein measurement | 2.48e-04 | 21 | 174 | 3 | EFO_0010599 | |
| Disease | Huntington's disease (is_marker_for) | 2.73e-04 | 53 | 174 | 4 | DOID:12858 (is_marker_for) | |
| Disease | Osteogenesis imperfecta, dominant perinatal lethal | 3.42e-04 | 5 | 174 | 2 | C0268358 | |
| Disease | osteogenesis imperfecta (implicated_via_orthology) | 3.42e-04 | 5 | 174 | 2 | DOID:12347 (implicated_via_orthology) | |
| Disease | Lobstein Disease | 3.42e-04 | 5 | 174 | 2 | C0023931 | |
| Disease | Ehlers-Danlos Syndrome | 3.42e-04 | 5 | 174 | 2 | C0013720 | |
| Disease | Heart valve disease | 4.74e-04 | 26 | 174 | 3 | C0018824 | |
| Disease | leiomyosarcoma (is_marker_for) | 5.11e-04 | 6 | 174 | 2 | DOID:1967 (is_marker_for) | |
| Disease | Osteoporosis | 5.11e-04 | 6 | 174 | 2 | cv:C0029456 | |
| Disease | Ehlers-Danlos syndrome (implicated_via_orthology) | 5.11e-04 | 6 | 174 | 2 | DOID:13359 (implicated_via_orthology) | |
| Disease | interleukin-1 receptor-like 1 measurement | 5.11e-04 | 6 | 174 | 2 | EFO_0801713 | |
| Disease | Ulcerative Colitis | 5.31e-04 | 63 | 174 | 4 | C0009324 | |
| Disease | upper respiratory tract disorder | 5.92e-04 | 28 | 174 | 3 | MONDO_0004867 | |
| Disease | JT interval | 7.03e-04 | 248 | 174 | 7 | EFO_0007885 | |
| Disease | lethal congenital contracture syndrome (is_implicated_in) | 7.12e-04 | 7 | 174 | 2 | DOID:0060558 (is_implicated_in) | |
| Disease | Thymic Carcinoma | 7.12e-04 | 7 | 174 | 2 | C0205969 | |
| Disease | placental insufficiency (biomarker_via_orthology) | 9.46e-04 | 8 | 174 | 2 | DOID:3891 (biomarker_via_orthology) | |
| Disease | melanoma (is_marker_for) | 9.65e-04 | 33 | 174 | 3 | DOID:1909 (is_marker_for) | |
| Disease | QT interval | DTL BEND3 RFTN2 ZBTB42 CASZ1 LRIG3 PPARGC1A PHF20L1 KDM1B SLC12A7 | 1.33e-03 | 534 | 174 | 10 | EFO_0004682 |
| Disease | Profound Mental Retardation | 1.43e-03 | 139 | 174 | 5 | C0020796 | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 1.43e-03 | 139 | 174 | 5 | DOID:3908 (is_implicated_in) | |
| Disease | Mental Retardation, Psychosocial | 1.43e-03 | 139 | 174 | 5 | C0025363 | |
| Disease | Mental deficiency | 1.43e-03 | 139 | 174 | 5 | C0917816 | |
| Disease | Ceroid lipofuscinosis, neuronal 1, infantile | 1.51e-03 | 10 | 174 | 2 | C2931673 | |
| Disease | Osteogenesis imperfecta type IV (disorder) | 1.51e-03 | 10 | 174 | 2 | C0268363 | |
| Disease | nephritis (implicated_via_orthology) | 1.51e-03 | 10 | 174 | 2 | DOID:10952 (implicated_via_orthology) | |
| Disease | Osteogenesis imperfecta type III (disorder) | 1.84e-03 | 11 | 174 | 2 | C0268362 | |
| Disease | endometriosis, unipolar depression | 2.09e-03 | 43 | 174 | 3 | EFO_0001065, EFO_0003761 | |
| Disease | autoimmune thyroiditis (is_implicated_in) | 2.19e-03 | 12 | 174 | 2 | DOID:7188 (is_implicated_in) | |
| Disease | retinopathy of prematurity (biomarker_via_orthology) | 2.19e-03 | 12 | 174 | 2 | DOID:13025 (biomarker_via_orthology) | |
| Disease | focal segmental glomerulosclerosis (biomarker_via_orthology) | 2.19e-03 | 12 | 174 | 2 | DOID:1312 (biomarker_via_orthology) | |
| Disease | asthma exacerbation measurement | 2.27e-03 | 93 | 174 | 4 | EFO_0007614 | |
| Disease | ureteral obstruction (biomarker_via_orthology) | 2.38e-03 | 45 | 174 | 3 | DOID:5199 (biomarker_via_orthology) | |
| Disease | diabetic retinopathy (biomarker_via_orthology) | 2.38e-03 | 45 | 174 | 3 | DOID:8947 (biomarker_via_orthology) | |
| Disease | Acute Promyelocytic Leukemia | 2.54e-03 | 46 | 174 | 3 | C0023487 | |
| Disease | male infertility (implicated_via_orthology) | 2.58e-03 | 13 | 174 | 2 | DOID:12336 (implicated_via_orthology) | |
| Disease | Osteogenesis Imperfecta | 2.58e-03 | 13 | 174 | 2 | C0029434 | |
| Disease | chronic obstructive pulmonary disease (is_marker_for) | 2.64e-03 | 97 | 174 | 4 | DOID:3083 (is_marker_for) | |
| Disease | myocardial infarction (biomarker_via_orthology) | 2.65e-03 | 160 | 174 | 5 | DOID:5844 (biomarker_via_orthology) | |
| Disease | Liver Cirrhosis | 3.28e-03 | 103 | 174 | 4 | C0023890 | |
| Disease | Fibrosis, Liver | 3.52e-03 | 105 | 174 | 4 | C0239946 | |
| Disease | melanoma | 3.63e-03 | 248 | 174 | 6 | C0025202 | |
| Disease | sarcoidosis (is_implicated_in) | 3.93e-03 | 16 | 174 | 2 | DOID:11335 (is_implicated_in) | |
| Disease | Dermatitis | 3.93e-03 | 16 | 174 | 2 | C0011603 | |
| Disease | diabetic retinopathy (implicated_via_orthology) | 3.93e-03 | 16 | 174 | 2 | DOID:8947 (implicated_via_orthology) | |
| Disease | gout, hyperuricemia | 3.93e-03 | 16 | 174 | 2 | EFO_0004274, EFO_0009104 | |
| Disease | Nasal Cavity Polyp | 4.22e-03 | 55 | 174 | 3 | EFO_1000391 | |
| Disease | Oral Submucous Fibrosis | 4.97e-03 | 18 | 174 | 2 | C0029172 | |
| Disease | blood nickel measurement | 5.64e-03 | 120 | 174 | 4 | EFO_0007583 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| CGKGYSQFTSLAEHQ | 361 | Q86Y25 | |
| HSAKGFKQSANLYCT | 511 | Q12979 | |
| SLQTEICSQNKYTHF | 326 | Q8NDB2 | |
| CTEQNFISKSGYHQS | 56 | P10768 | |
| HTYNKNSSACENSGY | 201 | Q969T7 | |
| TTECNVNHKGNFYCA | 166 | Q8IZF5 | |
| FHQHGCSTNDTNAKY | 91 | Q9NP61 | |
| AQKEHTFTIQAYDCG | 101 | Q9BQT9 | |
| FHSGFQTCAKEVLQY | 131 | Q9C0J9 | |
| GTADCQFYGQKTTHF | 596 | Q86V15 | |
| YEHSFNKSGSLRQCF | 1196 | Q86SQ4 | |
| NITVCAFHYESQNST | 176 | P30556 | |
| NTSYRSGENLNLSCH | 246 | P06731 | |
| SYTCQAHNSDTGLNR | 296 | P06731 | |
| SLSINDGFHVYQKGC | 56 | Q04771 | |
| KKQYQVQHGSCSYTF | 31 | O15123 | |
| KTALYFGVSNNDVHC | 351 | Q8WXK1 | |
| LCDSHSYSQTEGNQF | 2271 | Q8TDJ6 | |
| FNGHQNSTFYVKSSL | 311 | Q9NZJ0 | |
| QDNEGQTALHYASAC | 221 | Q9BR61 | |
| NTYKANGSAVCEAAH | 66 | Q9BXT2 | |
| FNNATHTSRPKCNSY | 1666 | Q9ULI1 | |
| YNSSTVKAHGNSCPQ | 726 | Q09MP3 | |
| NLINNTCFYTKNGHS | 286 | Q96S59 | |
| GVISNKAHQSYCHSN | 516 | Q96S59 | |
| NQSFESCVKINSHNY | 96 | P57052 | |
| ISQHYSPSKFCNGTN | 161 | Q52LD8 | |
| YHFQKTFTVSQAGNC | 436 | Q6PCD5 | |
| VSKSANYCHTSQGDP | 901 | P09874 | |
| SYNLCIAHTGTKEFN | 751 | Q9Y5F9 | |
| FTHENLRKQYNCSGS | 586 | Q5T5X7 | |
| DFQTNHTLKQTLSCY | 111 | O76096 | |
| TNYFASKCAENPNSN | 1526 | P23467 | |
| SGLHRTYSQDCSFKN | 941 | Q86U86 | |
| TNASCEYSASHKQDL | 151 | O95256 | |
| HFSCYSDPEGNQKSV | 171 | Q9Y691 | |
| CIAHSYKIYSNAGEQ | 241 | P41594 | |
| NNTDCTHFYKLGVKT | 2626 | Q9NZR2 | |
| NIHKFSNCDTSLSPY | 406 | Q96JY0 | |
| YAAQHLKAQSGDFLC | 2756 | Q5T1H1 | |
| NVTQEHFGNYTCVAA | 286 | Q7Z3B1 | |
| TCTNKHGLSNSIYVF | 96 | P10721 | |
| GNYTCVASNKLGHTN | 291 | Q9P121 | |
| EGKYQCVISNHFGSS | 576 | Q6UXM1 | |
| NQIKAFLSSHCYNAA | 31 | Q9P2D0 | |
| CLFDIGKNFSNSQEH | 136 | Q17R60 | |
| PANSYSNKGETSCHQ | 296 | Q6UXG2 | |
| CSFNSQNKYIGESLA | 981 | O60318 | |
| ATKCVTQYEGHVNNS | 301 | Q8NA75 | |
| SSGQDHLLTAYNQCV | 336 | Q6ZQW0 | |
| CNKNGFYHSRQCETS | 206 | P08833 | |
| ESDHSSLNNKYLNGC | 566 | Q8IXT1 | |
| HTDEIFSCAFNYKGN | 386 | Q8N136 | |
| YDHQNDGASQALASC | 176 | P49257 | |
| QAAFNICANSSLHDY | 316 | P49279 | |
| SCYSQLEVNGSQHSL | 41 | P16871 | |
| ANLHSKEYSENKSFC | 191 | O95749 | |
| HSYFSLTFCVQVQGK | 266 | P29460 | |
| SVGTNQSYQESHCFS | 216 | A2RRP1 | |
| SCNFIISNGGAQTYH | 146 | P22059 | |
| YTCVATNAAGETQQH | 1896 | Q96RW7 | |
| FVNVTHNGTYQCQAS | 451 | P32942 | |
| HNGTYQCQASSSRGK | 456 | P32942 | |
| RQHQGTYTCIASNAA | 5441 | Q5VST9 | |
| LSYNECSGLSTQNHA | 156 | Q9UBK2 | |
| FGDHDYCQSINSKTE | 381 | Q9UBK2 | |
| SGHYFDEKNLQSSQF | 1186 | O94913 | |
| GNYACQAILTHSGKQ | 191 | Q9HB29 | |
| TYDSFCSNGVTHRNQ | 381 | P05107 | |
| ANYASQNITYHCKNS | 1261 | P08123 | |
| CSNIQEIFQTLYSHG | 371 | P23508 | |
| CKFIHNENGANYSVT | 181 | Q01638 | |
| RGNYICKAQNSVGHT | 2501 | Q6WRI0 | |
| SNLEYACGSNLHQVS | 541 | Q8NB78 | |
| NEQGHYDAVTGKFTC | 131 | Q9BXJ0 | |
| CNIIHTEIFGFSNNY | 111 | Q9BVC3 | |
| LFTFYHISCQQKQGA | 646 | Q8NF50 | |
| KFTSQLLDQGTSQCY | 606 | O15228 | |
| AQKSHSGAYQCFATR | 376 | Q8TD84 | |
| LKHNGNYTCIASNAA | 661 | Q8TD84 | |
| ESNSNQCVYAAHNSV | 531 | P43004 | |
| TNCQTNSTHDPYAKA | 201 | Q8N118 | |
| NIKLQNFSSYSTSGC | 301 | Q9NY37 | |
| GQCQSHYSALQAAVA | 441 | O43281 | |
| KRCHGSQASYLFQQD | 326 | Q9Y600 | |
| IYTCSAKHAAVNTGQ | 571 | O75342 | |
| NKSFHTQYGEEENCH | 336 | Q8NFN8 | |
| TGVCNVDHQNKAGYT | 846 | Q5T7N3 | |
| FGTQTYTCNVDHKPS | 76 | P01859 | |
| HTDAICSVNYNSSAN | 261 | Q05048 | |
| DACVKAYGIHNNSAT | 321 | Q9Y666 | |
| VGQNHAYFKVCSQSL | 981 | Q6ZTR5 | |
| RYNESLTNFSCHGKN | 441 | Q9ULM6 | |
| SFLSCQETQAAAHNY | 106 | A0A1W2PPM1 | |
| QHTYSCLFGTFLCNN | 506 | Q13615 | |
| LSNYHQYIVKCHGNT | 166 | Q8TBX8 | |
| CGLSFFKENYSHLNA | 751 | A8MW92 | |
| QSHNKAISYAGCLTQ | 86 | P34982 | |
| YLNNQDSGTKAFCDV | 436 | Q9NYV6 | |
| CVKFHPNSNYLATGS | 431 | O75529 | |
| SLQTFTCLVGYKGHN | 571 | Q15542 | |
| PSVNSLHSVYNFCDK | 211 | P17600 | |
| LISFSSYNSVHNNCE | 286 | Q695T7 | |
| GCSTELNHLGYQFVQ | 296 | Q8IXI1 | |
| LKGIGETFCQHYTQS | 431 | P28749 | |
| LACYKGTHNFHNFTS | 236 | Q9Y606 | |
| KQFNYTHICAGASAF | 101 | P13804 | |
| IEGEANKYIAHSCNF | 66 | Q8NA58 | |
| NTYLCHDNLSSNDTK | 381 | Q5VXU9 | |
| ANNGHASSSCSQKYD | 96 | Q96JW4 | |
| SSYTFKQGHECPEQA | 481 | Q8NC67 | |
| LYRNGQVCFSTQDHK | 156 | O75688 | |
| KPNYTSADCQAHHQF | 161 | Q8TBJ4 | |
| VNLFAGKFYHCINTT | 1366 | P35498 | |
| QCAVAKNSAAYHSKG | 201 | Q9UQB8 | |
| KFYHSNSGAQLSHCK | 806 | Q9ULV3 | |
| EASQNITYHCKNSVA | 1361 | P02452 | |
| QAFTSGNYDACLQHL | 36 | Q9H9A5 | |
| QCNESGKAFNYSSVL | 216 | Q96IR2 | |
| SCRPKTHISNNYGDN | 181 | Q8N782 | |
| TFNSCYTVNHKQFSL | 51 | O60939 | |
| QKSSYNGIHQCLSAT | 126 | A8MUV8 | |
| CGKAFNQSYQLTRHK | 501 | Q9UII5 | |
| YKHCTVSGQTDAAKN | 2316 | Q86UP3 | |
| ECGSTFNNVYQLTLH | 191 | Q8NDQ6 | |
| CSKTFANSSYLAQHI | 261 | Q8TF68 | |
| HCSKTFANTSYLAQH | 321 | Q8TF68 | |
| CGKAFSQSAYLLNHQ | 431 | O14709 | |
| GKYANVFHKCSNSNR | 116 | Q8N7Q3 | |
| NLKYDHTTACTQQDS | 101 | P15622 | |
| SCGKAFSQYSVLIQH | 511 | P15622 | |
| HKGSYNGFNQCLTTT | 126 | A8MTY0 | |
| CGKTYTTGSKLFQHQ | 391 | Q86YE8 | |
| ACGKGFTQLSSYQSH | 256 | Q96K58 | |
| CGKAFNRSSYVTQHQ | 381 | Q8TB69 | |
| CGKAFIYSSSLNQHQ | 681 | Q9HBT7 | |
| SDNDFGRYNCTATNH | 466 | O15394 | |
| FHISGVTYNDNCENA | 51 | Q86T26 | |
| SKPSDCNFISNFYSH | 341 | Q9UBZ9 | |
| FSSNIHTYHVGKQCF | 151 | Q496A3 | |
| KFQYENSHGSSECIK | 671 | Q9P2N2 | |
| KQNANGHSCLSDVEY | 346 | Q8N394 | |
| YHCNNSEKTLNQSSS | 216 | Q14586 | |
| CGKAFNSRSYLIAHQ | 721 | Q14586 | |
| TQCGKSFQYSHNLSR | 441 | Q99592 | |
| SQHDLGSYVCKANNG | 301 | P35916 | |
| CGKAFSRGYQLSQHQ | 136 | Q9NQX6 | |
| ANKAVCRTNGFYSLH | 446 | Q6UXI7 | |
| NKCAVAFYSGKSHHN | 216 | Q13398 | |
| PSFQLQSHKNYEGTC | 76 | Q12968 | |
| YLNNQDSGTKAFCDV | 61 | Q2M238 | |
| GKYFSCGSNLIQHQS | 171 | Q9Y6R6 | |
| INVQYKLHSSGANCS | 436 | P07949 | |
| YGKAFNESSNCTTHK | 206 | Q6ZMV8 | |
| QSNPFCSYSEHQEKN | 606 | Q6IQ21 | |
| ECGKAFNQYSNLTTH | 766 | P17038 | |
| YECNQCGKTFSQRTH | 826 | Q5TYW1 | |
| ECGKRFTQNSQLYSH | 516 | Q9UK10 | |
| CGKGFSQSSYLQIHQ | 536 | Q9NYT6 | |
| QCGKSFQYSHNLSRH | 366 | B2RXF5 | |
| QCGKSFSQSYVLVVH | 581 | Q9UJW8 | |
| ECGKVFSNNSYLARH | 291 | Q8WV37 | |
| HKEGYNGLNQCFTTT | 126 | A6NNF4 | |
| YEECGKAFNQSSHLT | 451 | Q9P255 | |
| KQCGTAFNYHHSFQT | 156 | Q9H7R0 | |
| QRGKYANVFHKCSNS | 146 | O43345 | |
| CGKSFSQSYQLVAHK | 581 | Q6NX49 | |
| YKCNEHGQVFRASAS | 186 | Q3MIS6 | |
| CGKVFNQASYLTRHQ | 526 | Q3MIS6 | |
| HSCGNTYLSESQIQS | 176 | Q86WZ6 | |
| ESGDCFNKSSFHSYQ | 301 | Q86WZ6 | |
| GLTSIKGNCHNFYTA | 11 | H0UI37 | |
| AAAGCATTYNKHINI | 6 | Q9H0W7 | |
| YECNQVQKFISHSSS | 131 | Q5HY98 | |
| CGKAFYSGSSLTQHQ | 431 | Q14585 | |
| TCEATVNGHLYKTNY | 206 | P17948 | |
| VEECFHGENQYSKSS | 781 | Q6N021 | |
| GQCSQNEYFDSLLHA | 6 | Q02223 | |
| FYADTQSCTHSLQGQ | 2156 | P01266 | |
| NQYVSHDCDGAALTK | 16 | Q07283 | |
| KLACTHTGIQFYQFS | 106 | Q9Y4E6 | |
| CGKAFSQSSYLIQHQ | 331 | Q9NQZ8 | |
| ECGKSFNQSSHLYAH | 351 | Q14590 | |
| GNTHDCNQYGKDFLT | 171 | Q9BUY5 | |
| DGHTYSSVCKLEQQA | 151 | Q92563 | |
| ECGKSFSQSYNLAIH | 306 | Q6ZNA1 | |
| ECGKAFSYLSNLNQH | 506 | Q99676 | |
| QCGKSFSYSNSFQLH | 496 | Q14584 | |
| NTSLYLCDNKFHTEA | 121 | P62495 | |
| NFTDEGKYQCIVTNH | 571 | O94898 | |
| YQLCASAQQSEFKHL | 261 | Q9NQX4 |